The CiteAb Lifetime Achievement Award recognises and promotes an individual who has made an outstanding contribution to the research antibody industry over a sustained period of time (view past winners).
We’re thrilled to announce that Karen Padgett, Founder of Novus Biologicals and now Vice President of the Antibody Business Unit and Digital Marketing at Bio-Techne, has been selected as the worthy winner of this award.
Those nominating Karen said:
“Karen Padgett, has earned her place as a global leader in the research antibody industry, through her unfailing commitment, drive and positivity over the last two decades, and without ever compromising the integrity that defines her company as an industry leader.”
“Karen’s industry leadership and influence has also been exhibited through enthusiastic support of various antibody industry and publisher initiatives to improve validation standards, including the F1000Research Antibody Validation Channel, the 2nd International Antibody Validation Meeting, Affinity Binder Knockdown Initiative, and The Science Exchange Cancer Biology Reproducibility Project.”
Dr Andrew Chalmers, Founder of CiteAb, said: “Judges for this award looked for a contribution that went beyond commercial success. Karen founded Novus Biologicals and developed the company, which was eventually purchased for $60million. She continues to drive growth in the newly formed Bio-Techne.
“However, in addition to the growth of a powerful brand, Karen’s contribution reaches further. Throughout her career, she has had a very clear focus on building collaborations with industry and academics and has been central to many initiatives that have resulted in the improvement of validation standards. She has also invested in the next generation of researchers through a long-standing worldwide student scholarship programme.
“Karen is widely respected and well-liked by her industry peers, not an easy feat for any individual while also generating positive commercial growth year-on-year. She is a very deserving winner of this prestigious award and along with my colleagues at CiteAb I wish her many congratulations.”